A87689 compounds

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 1/04 (2006.01) A61K 35/74 (2006.01) C07G 11/00 (2006.01) C12N 1/20 (2006.01) C12P 1/06 (2006.01)

Patent

CA 2075163

X-8826M Abstract of the Invention Fermentation product A87689 is produced by a strain of Amycolatopsis mediterranei selected from NRRL 18815 and NRRL 18851, or an A87689-producing mutant thereof. A87689, its C1-6-alkyl ether and C1-6-alkanoyl ester derivatives and pharmaceutically acceptable salts thereof are phospholipase A2 inhibitors that are useful as antiinflammatory agents. Fermentation products known as BU-3889V, its components and pharmaceutically acceptable salts thereof, are phospholipase A2 inhibitors that are alæo useful as antiinflammatory agents. A87689 compounds, including its C1-6-alkyl ether and C1-6-alkanoyl derivatives, used alone or in combination with nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors and HIV protease inhibitors, are also useful for managing retroviral infections in mammals and are particularly useful for managing HIV and/or AIDS in humans.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A87689 compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A87689 compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A87689 compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1474593

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.